Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Revenue (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Revenue for 2 consecutive years, with $251000.0 as the latest value for Q1 2024.

  • For Q1 2024, Revenue changed N/A year-over-year to $251000.0; the TTM value through Dec 2024 reached $251000.0, changed N/A, while the annual FY2024 figure was $251000.0, 99.25% down from the prior year.
  • Revenue hit $251000.0 in Q1 2024 for Artiva Biotherapeutics, down from $2.4 million in the prior quarter.
  • Across five years, Revenue topped out at $26.7 million in Q3 2023 and bottomed at $251000.0 in Q1 2024.